Font Size: a A A
Keyword [Radioiodine]
Result: 21 - 40 | Page: 2 of 5
21. Clinical Study Of 131Ⅰ For The Treatment Of Bone Metastases From Differentiated Thyroid Cancer
22. Clinical Study Of Removing Residual Tissue After The Ablation Of Thyroid Cancer By 131Ⅰ Plus Lithium Carbonate
23. The Effect Of Different Levels Of Serum FT3 Concentration On The Turnover Rate Of Radioiodine In Graves Disease
24. The In Vivo Study On Radioiodine Uptake In Hepatoma Cells Mediated By Recombinant Adenovirus Encoding Human Sodium Iodide Symporter Gene
25. The Study On Correlation Between Serum Levels Of TGAb And TPOAb In Patients With Hyperthyroidism And Hypothyroidism After Radioiodine Treatment
26. Expression Of Ndrg2in Human Medullary Thyroid Carcinoma And Preliminary Study On Its Function
27. Experimental Study Of Dual Promoter Baculovirus-mediated Radioiodine Tumor Targeted Therapy Combined Withanti-tumorangiogenesis
28. Papillary Thyroid Carcinoma With Lung Metastases:Clinical Outcomes And Influencing Factors Of Radioiodine Therapy
29. Related Research On 24h Radioiodine-131 Uptake Rate And Time Of Dffective Half Life For Patients With Graves’ Disease
30. The Study Of Radioiodine Therapy Mediated By Transfer Of HNIS Gene Into Glioma Cell Controlled By HTERT Promoter In Vivo
31. The Effect Of Radioiodine And Methimazole On The Development Of Thyroid Associated Ophthalmopathy
32. The Impact Of Radioiodine Therapy On Quality Of Life In Patients With Differentiated Thyroid Carcinoma
33. A Systematic Review Of The Published RCTs Was Used To Compare The Success Rates Of Remnant Thyroid Tissue Ablation Using Low Dose Or High Radioiodine Dose
34. Study On The Individual-dose Of Radioiodine-131Therapy For Graves’ Disease
35. The Dose Analysis Of Radioiodine-131Treatment In Pediatric Patients With Graves’ Hyperthyroidism
36. Glial Fibrillary Acidic Protein And Human Telomerase Reverse Transcriptase Dual-promoters Direct Sodium Iodide Symporter Expression For Malignant Glioma Radioiodine Therapy
37. Thyroid Autoimmunity Antibody For Early Hypothyroidism Following Graves’ Disease After Radioiodine Therapy
38. Evaluation Of SPECT Imaging And The Internal Therapeutic Effectiveness Of 131I-EGFR-BSA-PCL In The Colorectal Cancer Mouse Model
39. Efficacy Of 131I Therapy For Cervical Lymph Node Metastasis In Papillary Thyroid Carcinoma And Analysis Of The Related Factors
40. The Clinical Research Of Radioiodine-refractory Differentiated Thyroid Cancer With Distant Metastasis
  <<First  <Prev  Next>  Last>>  Jump to